Addressing the challenge of antimicrobial resistance
- PMID: 40050472
- PMCID: PMC11885620
- DOI: 10.1038/s43856-025-00758-1
Addressing the challenge of antimicrobial resistance
Abstract
Antimicrobial resistance (AMR) is a global health challenge that requires cross-disciplinary collaboration to mitigate its impact on human health. We discuss some of the topical advances in the field, highlighting the
Conflict of interest statement
Competing interests: The authors declare competing interests. T.M.R. has received honoraria from Sandoz, bioMerieux, Pfizer, and Roche Diagnostics. L.S.P.M. reports consulting fees from Umovis Lab and Pulmocide and payment or honoraria from bioMerieux, Eumedica, Pfizer, and Shionogi. M.L. has no conflicts of interest to declare.
References
-
- O’Neill, J. Tackling drug-resistant infections globally: final report and recommendations. Review on antimicrobial resistance. (2016).
-
- United Nations. Draft political declaration of the high-level meeting of the general assembly on antimicrobial resistance. 16108 (2016).
Publication types
LinkOut - more resources
Full Text Sources